Oticon Intent Expert Review

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.70/5, ranking #1 among 35 prescription hearing aids tested.

Speech performance is a standout strength. Speech in quiet scored an excellent 4.6/5, measuring 1.17 points above the category average. Speech in noise delivered a solid 3.7/5, an impressive 2.17 points above the typical prescription device—one of the largest margins we've measured in this category. Feedback handling achieved a perfect 5.0/5, and music streaming scored a strong 4.0/5, sitting 1.39 points above average for clear, enjoyable audio from connected devices.

The notable weakness is own-voice comfort, which scored a low 1.3/5—falling 1.43 points below the category average. Users sensitive to the sound of their own voice may find this less comfortable, particularly in the early adjustment period.

The Oticon Intent is best suited for those prioritizing speech understanding in challenging listening environments and high-quality streaming. It competes closely with the Phonak Sphere Infinio (4.64/5) and Signia devices in the same premium tier. This two-time Expert's Choice Award winner (2023, 2024) offers rechargeable batteries and hands-free connectivity with both iPhone and Android devices.